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Abstract. QSAR (2D and 3D) studies were performed on a 
series of Camptothecin derivatives using Material Studio 
software (accelrys). QSAR study performed on 102 ana-
logues of which 90 were used in the training set and the 
rest 22 considered for the test set.  QSAR study performed 
using Genetic function approximation (GFA). GFA method 
came out with good correlation coefficient R2train =0.837 , 
cross-validated coefficient Q2CV=0.792 and R
2
Test of 0.9408. 
A highly predictive and statistically significant model was 
generated. The QSAR models were found to accurately pre-
dict the anticancer activity of structurally diverse test set 
compounds and to yield reliable clues for further optimiza-
tion of the of Camptothecin derivatives in the data set. 
 
Keywords: Anticancer agents, Genetic Function Approximation, 
QSAR.  
 
Introduction. Cancer is a major problem worldwide and is the 
primary cause of death in developed countries. Almost one in 
two men and more than one in three women in the United 
States will be diagnosed with cancer at some point in his or her 
days [1]. One of the most difficult problems arising during can-
cer therapy is the occurrence of cancer cell invasion responsible 
for the spread of tumor cells throughout the body [2]. Despite 
several efforts in the treatment of cancer, because of several 
limitations that using medications has, this disease became a 
big problem for the health of societies. The purpose is to devel-
op medications with more anticancer activity and less toxicity 
than the present medications [3]. Computational chemistry is 
currently an important contributor to rational drug design [4]. 
The molecular and chemical computing models are used in de-
signing new medications which resulted in saving time and cost 
and designing medications with more potential. Among various 
computational methods, QSAR has a remarkable role in design-
ing a medication. Quantitative structure-activity relationship 
(QSARs) is an attempt to correlate structural or property de-
scriptors of compounds quantitatively with biological activities. 
The physicochemical descriptors include parameters account for 
constitutional, fragment constant, thermodynamic, conforma-
tional, hydrophobicity, topology, electronic properties, steric 
effects, hydrogen bond-donor, hydrogen bond acceptor are 
determined empirically or, more recently, by computational 
methods [5]. QSAR models are mathematical equations which 
relate the chemical structure of compounds to their biological 
activity [6]. The fundamental idea of QSAR consists of the possi-
bility of a relationship between a set of descriptors, which are 
derived from molecular structure, and a molecular response. 
Within this scope, several molecular descriptors, which discrete-
ly parameterize a given molecular set, have been devised. 
Quantum chemical calculations are thus an attractive source of 
new molecular descriptors, which can, in principle, express all of 
the electronic and geometric properties of molecules and their 
interactions [7]. The purpose of the present paper was to find 
more representative 3D descriptors able to discriminate HL-60 
cell lines. The intention was also to develop QSAR models for 
HL-60 cell lines inhibitory effect of the aforementioned set of 
compounds using selected molecular descriptors and physico-
chemical parameters. The obtained results should give a contri-
bution for better understanding of the binding ability of Camp-
tothecin derivatives. 
 
Matherial and Methods. Data sources. In this study, a data set 
of eighty-five (85) compounds from NCI database were opti-
mized at the density functional theory (DFT) level using Becke's 
three-parameter Lee-Yang-Parr hybrid functional (B3LYP) in 
combination with the 6-31G* basis set [8, 9]. The optimized 
structures were employed in the generation of quantum chemi-
cal and molecular descriptors. These were then divided into 
training and test sets by Kennard Stone algorithm [10]. The 
QSAR models were generated using the Genetic Function Ap-
proximation (GFA). The GFA technique is a conglomeration of 
Genetic Algorithm, Friedman’s multivariate adaptive regression 
splines (MARS) algorithm and Holland’s genetic algorithm to 
evolve population of equations that best fit the training set data 
[11, 12]. Geometry optimization Chemical structures of the 
compounds were drawn using the ChemDraw software 
(CambridgeSoft 2010), while the molecular geometries were 
optimized using Spartan 14 software (Spartan 14v114) [13]at 
the density functional theory (DFT) level using Becke's three-
parameter Lee-Yang-Parr hybrid functional (B3LYP) in combina-
tion with the 6-31G* basis set. The Spartan 14 software also 
resulted in the generation of a set of quantum chemical de-
scriptors. Descriptors calculation The low energy conformers 
were then submitted for further generation of an additional set 
of molecular descriptors using the software "PaDel-Descriptor 
version 2.20" [14]. Different physicochemical descriptors were 
calculated for each molecule presented in Table 1. These de-
scriptors included electronic, spatial, structural, thermodynamic 
and topological. This was combined to the set of quantum 
chemical descriptors obtained from the low energy conformer 
of the structures as generated by Spartan 14 Wavefunction soft-
ware. Data Pre-Treatment/Feature Selection. It is observed 
that constant value and highly correlated descriptors may cause 
difficulties in forming QSAR models, hence the predictivity and 
generalization of the model fails under these conditions. In or-
der to overcome this problem, the pre-processing for the gen-
erated molecular descriptors was done by removing descriptors 
having constant value and pairs of variables with correlation 
coefficient greater than 0.7 using "Data Pre-Treatment GUI 1.2" 
tool that uses V-WSP algorithm [15], [16]. Dataset Division. The 
dataset of eighty-five (85) molecular structures was split into 
training and test set by Kennard Stone algorithm technique 
using the software "Dataset Division GUI 1.2" [17]. This is an 
application tool used to perform rational selection of training 
and test set from the data set. QSAR Model Development and 
Validation. The QSAR model were developed from the train-
ing set compounds where the independent variables quan-
tum chemical and molecular descriptors and the dependent 
response variable (pGI50) were subjected to multivariate analy-
sis by Genetic Function Approximation (GFA) technique using 
the material studio software. GFA was performed by using 
800,000 crossovers, a smoothness value of 1.00 and other 
default settings for each combination. An initial of three and 
a maximum of five terms per equation were considered 
for model development. GFA measures the fitness of a model 
during the evolution process by calculating the Friedman lack-
of-fit (LOF). Model Validation The developed models were vali-
dated internally by leave- one- out (LOO) cross- validation tech-
nique. In this technique, one compound is eliminated from the data 
set at random in each cycle and the model is built using the rest of 
the compounds. The model thus formed is used for predicting the 
activity of the eliminated compound. The process is repeated until 
all the compounds are eliminated once. The Cross-validated 
squared correlation coefficient, R2cv (Q
2) was calculated using the 
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expression:  
 
 
 
 
 
Where Yobs represents the observed activity of the training set 
compounds, Ypred is the predicted activity of the training set 
compounds and Ȳ corresponds to the mean observed activity 
of the training set compounds. External validation was em-
ployed in order to determine the predictive capacity of the de-
veloped model as judged by its application for the prediction of 
test set activity values and calculation of predictive R2(R2pred) 
value as given by the expression:   
 
 
 
 
 
Where Ypred(Test) and Y(Test) indicate predicted and observed activity values 
respectively, of the test compounds. Ȳ(Training)  indicates mean activity 
value of the training set. R2pred is the predicted correlation coefficient 
calculated from the predicted activity of all the test set compounds. It 
has been observed that R2pred may not be sufficient to indicated the 
external predictability of a model since its value is controlled by  
∑(Y((Test))-Ȳ(Training) )
2. Thus R2pred depends on the training set mean 
and may not truly reflect the predictive capability of the developed 
model with regards to a new data set [18]. This may result in considera-
ble numerical difference between the observed and predicted values in 
spite of maintaining a good overall intercorrelation. 
 
Results and Disscussions. The total set of compounds was 
manually divided into a training set (90 compounds) for gener-
ating 2D-3D QSAR models and a test set (22 compounds) for 
validating the quality of the models. Selection of the training 
set and test set molecules was done on the basis of Kennard 
Stone algorithm technique (see section 2.5) and a wide range of 
activity such that the test-set molecules represent a range of 
biological activity similar to that of the training set; therefore, 
the test set is truly representative of the training set. This ap-
proach resulted in selection of compounds (see Table 1) as the 
test set and the remaining 90 compounds as the training set. 
Genetic approximation-multiple linear regression (GA-MLR) 
method is the standard method for multivariate data analysis. It 
estimates the values of the regression coefficients by applying 
least squares curve fitting method. For getting reliable results, 
dataset having typically 5 times as many data points 
(molecules) as independent variables (descriptors) is required. 
According to the statistical calculation, it was obtained the 
strong correlation between the topological, geometrical and 
functional group descriptors to the anticancer activity of the 
substituted analogue (leukemia cell line). The QSAR model have 
shown good correlation between their corresponding de-
scriptors and biological activity. The higher the F value is, the 
more significant the data would be. Data would be significant if 
Fcalc/Ftable > 1. According to the Fcalc/Ftable value, it indicated that 
the models fits in all cases was not a chance occurrence and all 
models were statistically significant. Based on the R2 criteria (R2 
> 0.6), the model was passed to validation step. To validate the 
selected prediction function, a cross-validation and an external 
test were carried out. Cross-validation is a practical and reliable 
method for testing the significance. The developed QSAR mod-
el were validated using the following statistical measures: Q2 
(coefficient of determination). A QSAR model is considered to 
be predictive, if the following conditions are satisfied: Q2 > 0.6. 
The Q2 values were used as deciding factors in selecting the 
optimal models. The predicted activities of the Leukemia cell 
line by the above model are shown in Table 2. The result of 
evaluation anticancer activity [predicted pGI50] and correlation 
with anticancer activity [experiment pGI50] for the model by 
using density functional theory (DFT) level using Becke's three-
parameter Lee-Yang-Parr hybrid functional (B3LYP) in combina-
tion with the 6-31G* basis set of test set and training set can be 
seen at Figure 1. From the Table 1 it is evident that the predict-
ed activities of all the compounds in the test set are in good 
agreement with their corresponding experimental activities and 
optimal fit is obtained generated by the QSARs utilizing differ-
ent set of topological, geometrical and functional group de-
scriptors. The statistically best significant model obtained by GA
-MLR method with R2 = 0.837 was considered, as the model 
showed good internal predictive power (Q2 = 0.792) of 79% 
and predictively for the external test set (R2test = 0.919 for 100% 
data and R2test = 0.941) of about 90%. Consequently, QSAR 
model can be considered as the most suitable model for anti-
cancer activity against leukemia cell line with both high statisti-
cal significant and excellent predictive ability. The best QSAR 
equation was as follows:  
 
pGI_50  =  - 1.624 (n-Hydroxy) + 3.150 (AATSC7s) 
                         + 4.855 (MATS3e) + 2.049 (GATS3s)   
                          - 2.114 (BCUTw-1h) + 2.913 (SpMin1_Bhv ) 
                         + 2.051 (nHBint7) - 2.440 (minHBint7) 
                         + 4.393 (WPSA-3) - 3.955 (RDF145v) - 0.941 
 
Ntrain=90, R
2
train=0.837, adjR
2
train=0.816, Ftrain=39.520, Q
2
CV=0.792 
Ntest= 22 Outliers=5 
Based on the coefficient of descriptor parameters involved in 
the QSAR model in which seen on the autocorrelation de-
scriptor, therefore the active region of analogues can be pre-
dicted. The predictive ability of the selected model was also 
confirmed by Q2f1, Q
2
f2, R
2
m, and Concordance Correlation Coef-
ficient (CCC) using LOO predicted values since we have sepa-
rate external data set [19]. The proposed QSAR model was pre-
dictive as it satisfies the following conditions for LOO validation 
method: Q2f1 = 0.9213 > 0.6, Q
2
f2 = 0.9158 > 0.6, R
2
m = 0.8867 
> 0.6 and CCC = 0.9572. The leverage values can be calculated 
for every compound and plotted vs. standardized residuals, and 
it allows a graphical detection of both the outliers and the influ-
ential chemicals in a model. Fig. 2, shows the Williams plot, the 
applicability domain is established inside a squared area within 
±3 bound for residuals and a leverage threshold h* (h* =3p’/n), 
where p’ is the number of model parameters and n is the num-
ber of compounds) [20]. It demonstrates that some of the com-
pounds of the training set (ID-15, 19, 63,84 and 90) are outside 
of this square area while all the test set are inside of this square 
area. From Fig. 2, it is obvious that of the compounds of the 
training set (ID-15, 19, 63, 84 and 90) are outlier compounds 
with standard residuals >3d for the training sets. Furthermore, 
the chemicals have a leverage higher than the warning h* value 
of 0.375. Interpretation of descriptors The ten-variable model 
adequately represents the pGI50 data, based on direct statistics 
as well as validation methods. Each of the variables is a de-
scriptor of an aspect of molecular structure and will be dis-
cussed to indicate the specific structure information encoded. 
By interpreting the descriptors contained in the QSAR model, it 
is possible to gain some insights into factors, which are related 
to the anticancer activity. For this reason, an acceptable inter-
pretation of the selected descriptors is provided below. The 
brief descriptions of descriptors are shown in Table 2. To exam-
ine the relative importance as well as the contribution of each 
descriptor in the model, the value of the mean effect (MF) was 
calculated for each descriptor [21]. MF values are –0.053, 0.300, 
0.397, 0.096, -0.041, 0.268, 0.058, -0.128, 0.138 and -0.045 for 
Hydroxyl, AATSC7s, MATS3e, GATS3s, BCUTw-1h, SpMin1_Bhv, 
nHBint7, minHBint7, WPSA-3 and RDF145v, respectively. The 
two 2D-descriptors, AATSC7s which correspond to Average 
centered Broto-Moreau autocorrelation - lag 7 / weighted by I-
state, have positive mean effect (MF) which means they have 
positive impact on activity; therefore in the future, their values 
should be kept as high as possible. The high value of mean 
effect for MATS3e shows the significance of this descriptor in 
the model. MATS3e (Moran autocorrelation - lag 3 / weighted 
by Sanderson electronegativities) belongs to the 2D autocorre-
lation descriptors. The 2D autocorrelation descriptors have 
been successfully employed by Duchowicz et al. (2005) [22]. In 
these descriptors, the molecule atoms represent a set of dis-
crete points in space, and the atomic property and function are 
evaluated at those points. The physico-chemical property for 
MATS3e descriptor is Sanderson electronegativities, which re-
late to the electronegativities of the molecule.  
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ID Nr. NAME NSC 
HL-60 
(Experimental 
pGI50) 
HL-60 
(Predicted 
pGI50) 
1 11-FORMYL-20(RS)-CAMPTOTHECIN 606172 5.9 6.477 
2 11-HYDROXYMETHYL-20(RS)-CAMPTOTHECIN 606173 - - 
3 14-CHLORO-20(S)-CAMPTOTHECIN HYDRATE 643833 5.7 6.445 
4 2'-DEOXY-5-FLUOROURIDINE 27640 6.2 5.427 
5 3-HP 95678 6.3 6.035 
6 5,6-DIHYDRO-5-AZACYTIDINE 264880 6.1 6.389 
7 5-AZA-2'-DEOXYCYTIDINE 127716 4.2 3.759 
8 5-AZACYTIDINE 102816 6.3b 6.325 
9 5-HP 107392 5.4 b 5.462 
10 7-CHLOROCAMPTOTHECIN 249910 8.0 b 6.337 
11 9-AMINO-20-(R,S)-CAMPTOTHECIN 629971 7.9 7.118 
12 ACIVICIN 163501 5.4 5.101 
13 ALLOCOLCHICINE 406042 8.0 7.807 
14 ALPHA-TGDR 71851 3.7 4.855 
15 AMINOPTERIN DERIVATIVE1 132483 *4.0 5.869 
16 AMINOPTERIN DERIVATIVE2 184692 7.5 6.679 
17 AMINOPTERIN DERIVATIVE3 134033 - - 
18 AMONAFIDE 308847 5.6 5.721 
19 AN ANTIFOL 623017 *8.0 7.780 
20 ANTHRAPYRAZOLE DERIVATIVE 355644 7.3 7.254 
21 APHIDICOLIN GLYCINATE 303812 6.5 6.000 
22 ARA-C 63878 6.8 6.125 
23 ASALEY 167780 6.3 6.204 
24 AZQ 182986 6.5 6.708 
25 BAKER'S SOLUBLE ANTIFOL 139105 6.9 b 5.664 
26 BCNU 409962 4.8 4.005 
27 BETA-TGDR 71261 5.9 4.457 
28 BISANTRENE HCL 337766 7.4 8.062 
29 BREQUINAR 368390 6.1 6.337 
30 BUSULFAN 750 3.9 4.016 
31 CAMPTOTHECIN 94600 7.9 7.157 
32 CAMPTOTHECIN ANALOG 295500 7.0 7.328 
33 CAMPTOTHECIN ANALOG2 606985 8.0 7.591 
34 CAMPTOTHECIN ANALOG3 295501 8.0 b 7.121 
35 
CAMPTOTHECIN BUTYLGLYCINATE ESTER HYDRO-
CHLORIDE 606499 7.1 7.789 
36 
CAMPTOTHECIN ETHYLGLYCINATE ESTER HYDRO-
CHLORIDE 606497 7.3 7.802 
37 CAMPTOTHECIN GLUTAMATE HCL 610459 7.7 b 7.429 
38 CAMPTOTHECIN HEMISUCCINATE SODIUM SALT 610456 7.5 7.030 
39 CAMPTOTHECIN LYSINATE HCL 610457 7.9 8.222 
40 CAMPTOTHECIN PHOSPHATE 610458 7.5 7.319 
41 CAMPTOTHECIN, 9-METHOXY- 176323 8.0 7.108 
Table 1: Experimental and Predicted toxicities on different leukaemia cell lines obtained with linear models based on GA-MLR 
technique. 
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ID Nr. NAME NSC 
HL-60 
(Experimental 
pGI50) 
HL-60 
(Predicted 
pGI50) 
42 CAMPTOTHECIN, ACETATE 95382 6.4 7.308 
43 CAMPTOTHECIN, HYDROXY- 107124 7.7 b 6.626 
44 CAMPTOTHECIN, NA SALT 100880 7.6 7.227 
45 
CAMPTOTHECIN,20-O-((4-(2-HYDROXYETHYL)-1-
PIPERAZINO)OAC 374028 6.6 7.693 
46 
CAMPTOTHECIN-20-O-(N,N-DIMETHYL)GLYCINATE 
HCL 618939 8.0 7.969 
47 CCNU 79037 4.7 4.609 
48 CHLORAMBUCIL 3088 5.1 5.390 
49 CHLOROZOTOCIN 178248 3.5 4.564 
50 CLOMESONE 338947 3.9 3.856 
51 COLCHICINE 757 7.2 b 7.778 
52 COLCHICINE DERIVATIVE 33410 8.0 7.993 
53 CYANOMORPHOLINODOXORUBICIN 357704 8.1 b 6.827 
54 CYCLOCYTIDINE 145668 6.5 5.478 
55 CYCLODISONE 348948 4.9 4.510 
56 DAUNORUBICIN 82151 7.2 6.972 
57 DEOXYDOXORUBICIN 267469 7.5 7.602 
58 DIANHYDROGALACTITOL 132313 5.3 6.271 
59 DICHLORALLYL LAWSONE 126771 5.7 5.962 
60 DOLASTATIN 10 376128 - - 
61 DOXORUBICIN 123127 7.2 b 7.617 
62 FLUORODOPAN 73754 4.2 4.476 
63 FTORAFUR (PRO-DRUG) 148958 *3.1 3.395 
64 GLYCINATE 364830 7.8 6.917 
65 GUANAZOLE 1895 2.9 3.013 
66 HEPSULFAM 329680 4.6 4.020 
67 HYCANTHONE 142982 - - 
68 HYDROXYUREA 32065 4.8 4.947 
69 INOSINE GLYCODIALDEHYDE 118994 4.1 b 5.337 
70 L-ALANOSINE 153353 5.0 5.352 
71 MACBECIN II 330500 7.0 6.715 
72 M-AMSA 249992 7.2 7.163 
73 MAYTANSINE 153858 7.9 b 6.570 
74 MELPHALAN 8806 5.6 5.480 
75 MENOGARIL 269148 6.9 b 6.625 
76 METHOTREXATE 740 - - 
77 METHOTREXATE DERIVATIVE 174121 9.4 8.586 
78 METHYL CCNU 95441 4.9 4.952 
79 MITOMYCIN C 26980 6.6 7.370 
80 MITOXANTRONE 301739 8.1 8.142 
81 MITOZOLAMIDE 353451 4.5 4.512 
82 MORPHOLINODOXORUBICIN 354646 8.6 8.016 
83 N-(PHOSPHONOACETYL)-L-ASPARTATE (PALA) 224131 3.6 4.086 
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ID Nr. NAME NSC 
HL-60 
(Experimental 
pGI50) 
HL-60 
(Predicted 
pGI50) 
84 N,N-DIBENZYL DAUNOMYCIN 268242 *4.7 5.183 
85 NITROGEN MUSTARD 762 6.7 5.957 
86 OXANTHRAZOLE 349174 6.3 6.839 
87 PCNU 95466 4.2 b 4.927 
88 PIPERAZINE DRUGSMAINATOR 344007 5.9 b 5.872 
89 PIPERAZINEDIONE 135758 7.0 6.567 
90 PIPOBROMAN 25154 4.8 4.586 
91 PORFIROMYCIN 56410 6.3 b 6.559 
92 PYRAZOFURIN 143095 6.3 b 7.139 
93 PYRAZOLOACRIDINE 366140 6.5 6.256 
94 PYRAZOLOIMIDAZOLE 51143 3.4 3.995 
95 RHIZOXIN 332598 8.0 6.732 
96 RUBIDAZONE 164011 7.1 7.074 
97 SPIROHYDANTOIN MUSTARD 172112 4.4 5.300 
98 TAXOL 125973 8.4 8.322 
99 TEROXIRONE 296934 6.2 b 6.310 
100 TETRAPLATIN 363812 6.2 6.259 
101 THIOCOLCHICINE 361792 7.6 7.082 
102 THIOGUANINE 752 5.9 b 5.855 
103 THIO-TEPA 6396 5.1 5.202 
104 TRIETHYLENEMELAMINE 9706 6.2 6.603 
105 TRIMETREXATE 352122 7.6 7.579 
106 TRITYL CYSTEINE 83265 6.3 7.135 
107 URACIL NITROGEN MUSTARD 34462 5.9 4.996 
108 VINBLASTINE SULFATE 49842 9.4 9.115 
109 VINCRISTINE SULFATE 67574 7.0 7.615 
110 VM-26 122819 7.2 6.268 
111 VP-16 141540 6.0 7.138 
112 YOSHI-864 102627 3.7 4.176 
Where superscript letters (b) represent test sets for the cancer cell line, and * identifies compounds found outside the applicabil-
ity domain (outliers) of the model 
Figure 1. The predicted pGI50 against the experimental value 
for the training and test sets of HL-60 leukaemia cell line.    
Figure 2: The Williams plot, the plot of the standardized resid-
uals versus the activity (pGI50) leverage value for HL-60 dataset 
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Therefore increasing the electronegativities of a molecule in-
creases its MATS3e value. Mean effect of BCUTw-1h has the 
negative sign, which indicates that an increase in the weight of 
molecule leads to a decrease in its anticancer activity. The factor 
that affects the activity positively is GATS3s, a 2D-descriptor, 
which corresponds to Geary autocorrelation - lag 3 / weighted 
by I-state. SpMin1_Bhv is one of the Burden modified eigen 
values descriptors. The SpMin1_Bhv descriptors have been pro-
posed as chemical structure descriptors derived from a new 
representation of molecular structure. SpMin1_Bhv is the 
Smallest absolute eigenvalue of Burden modified matrix - n 1 / 
weighted by relative van der Waals volumes. The SpMin1_Bhv 
mean effect has a positive sign. This sign suggests that the anti-
cancer activity is directly related to this descriptor. Electro topo-
logical state atom type descriptor nHBint7, represents Count of 
E-State descriptors of strength for potential Hydrogen Bonds of 
path length 7. This descriptor contributes positively which indi-
cates that inhibitory activity of camptothecin derivatives will 
increases with Hydrogen Bonds of path length 7. Negative con-
tribution of the minHBint7 (Minimum E-State descriptors of 
strength for potential Hydrogen Bonds of path length 7) indi-
cates that inhibitory activity of camptothecin derivatives will 
increases with decrease of the molecular descriptors. The 3D-
CPSA descriptor, WPSA-3, is the charged partial surface areas 
has positive mean effect that points out to enhance the activity, 
and its value should be kept as small as possible. WPSA-3 cor-
responds to 3D-CPSA descriptor PPSA-3 * total molecular sur-
face area / 1000. RDF145v is one of the 3D-radial distribution 
function (RDF) descriptors which were proposed based on a 
radial distribution function. The radial distribution function is 
probability distribution to find an atom in a spherical volume of 
radius  . RDF descriptors are independent of the size and rota-
Model biasness test SystematicErrorResult Absent 
  R^2Test(100% data) 0.9190 
  R0^2Test(100% data) 0.9180 
Classical Metrics Q2F1(100% data) 0.9213 
(for 100% data) Q2F2(100% data) 0.9158 
  Scaled Avg.Rm^2(100% data) 0.8867 
  Scaled DeltaRm^2(100% data) 0.0204 
  CCC(100% data) 0.9572 
  R^2Test(95% data) 0.9408 
Classical Metric R0^2Test(95% data) 0.9405 
(after removing Q2F1(95% data) 0.9446 
5% data with Q2F2(95% data) 0.9401 
Table 2: External Validation Result for H-60 cell line 
Descriptors Definition ME 
Hydroxyl number of hydroxyl group (Fragment 
Counts) -0.053 
AATSC7s 
Average centered Broto-Moreau auto-
correlation - lag 7 / weighted by I-
state 
0.300 
MATS3e 
Moran autocorrelation - lag 3 / 
weighted by Sanderson electronega-
tivities 
0.397 
GATS3s Geary autocorrelation - lag 3 / 
weighted by I-state 0.096 
BCUTw-1h Number of low highest atom weighted 
BCUTS -0.041 
SpMin1_Bhv 
Smallest absolute eigenvalue of Bur-
den modified matrix - n 1 / weighted 
by relative van der Waals volumes 
0.268 
nHBint7 
Count of E-State descriptors of 
strength for potential Hydrogen Bonds 
of path length 7 
0.058 
minHBint7 
Minimum E-State descriptors of 
strength for potential Hydrogen Bonds 
of path length 7 
-0.128 
WPSA-3 PPSA-3 * total molecular surface area / 
1000 0.138 
RDF145v 
Radial distribution function - 145 / 
weighted by relative van der Waals 
volumes 
-0.035 
Table 3: Specification of entered descriptors in genetic algorithm multiple regression model of H-60. 
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tion of the entire molecule. They describe the steric hindrance 
or the structure/activity properties of a molecule.  The RDF de-
scriptor provides valuable information about the bond distanc-
es, ring types, planar and nonplanar systems, and atom types 
[23]. The descriptors used for the constructed QSAR model in 
this work encoded electronic, geometrical, and topological as-
pects of molecules. Appearances of these descriptors in the 
model reveal the role of electronic and steric interactions in 
inducing anticancer pGI50 activity on HL-60 cell lines. 
 
Conclusions The model presented here, validated according to 
statistical criteria that are stricter than those typically used in 
QSAR studies, may serve as a guide for providing the structural 
requirements affecting the anticancer activities of camptothecin 
derivatives, through the identification of the most relevant se-
lected molecular descriptors in the models. However, we ap-
plied the developed QSAR to predict some unknown structural-
ly-related compound. We are particularly careful in validating 
the relationships with the Leave-One-Out Cross Validation 
method and by leaving some of the molecules as part of an 
external test set. Finally, the results presented in this work route 
to two different methodologies: (i) application of linear models 
for selecting the most relevant structural parameters, and (ii) 
engagement of flexible (property dependent) molecular de-
scriptors. The good statistical parameters, stability and robust-
ness of the model obtained, as assured by the validation tests 
applied over our data, indicate that these model can be used to 
design other camptothecin derivatives with improved anti-
cancer activity. 
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